Cover Image

Ara h 2 105‐124 ‐Specific TH2A Cells Drive Peanut Allergy in DRB1*15:01 Individuals: A Detailed Epitope Analysis

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Rebecca A. Gomez, Jue Hou, Vivian H. Gersuk, I‐Ting Chow, Mary L. Farrington, David Robinson, William W. Kwok
Format:	Artículo Open Access
Published:	Wiley 2025
Subjects:	Clinical & Experimental Allergy
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Efficacy and Safety of Ligelizumab in Individuals With Confirmed Peanut Allergy
by: Philippe Bégin, et al.
Published: (2026)

New Structural Insights Into the Potency and Cross‐Reactivity of the Major Peanut Allergen Ara h 2
by: Merima Bublin, et al.
Published: (2026)

Oral Immunotherapy of Peanut Allergy: A Critical Role for Gut‐Associated Immunity
by: A. Kuehn, et al.
Published: (2025)

Evaluation of Intestinal Permeability Using Serum Biomarkers in Learning Early About Peanut Allergy Trial
by: Ozge Nur Aktas, et al.
Published: (2025)

Colostrum as a Protective Factor Against Peanut Allergy: Evidence From a Birth Cohort
by: Maheshwar Bhasin, et al.
Published: (2025)

Oral and Gut Microbial Hubs Associated With Reaction Threshold Interact With Circulating Immune Factors in Peanut Allergy
by: Lingdi Zhang, et al.
Published: (2025)

Efficacy and Safety of Dupilumab in Children With Peanut Allergy: A Multicenter, Open‐Label, Phase II Study
by: Sayantani B. Sindher, et al.
Published: (2024)

Developing a Standardised National Model of Care for Treatment of Peanut Allergy in Infants: The ADAPT Peanut Oral Immunotherapy Program
by: T. W. Brettig, et al.
Published: (2025)

Adverse Effects of Dupilumab, Effects of Peanut OIT on the Gut Microbiome and Allergy Training in the United Kingdom
by: Mohamed H. Shamji, et al.
Published: (2025)

Correspondence: First Peanut ( Arachis hypogaea ) Allergen Oral Immunotherapy Product Out of Sale—A Major Drawback for Food Allergy Immunotherapy?
by: S. Arasi, et al.
Published: (2026)

Pragmatic Low‐Dose Oral Immunotherapy for Preschool Children With Peanut Allergy: A Randomised Controlled Trial
by: Michael O'Sullivan, et al.
Published: (2025)

Whole Blood Transcriptomics Identifies Differences in Innate Immune Pathway Expression in Infants at Risk for Peanut Allergy
by: Abigail Lang, et al.
Published: (2024)

Design of the Intervention to Reduce Early Peanut Allergy in Children ( iREACH ): A practice‐based clinical trial
by: Lucy A. Bilaver, et al.
Published: (2024)

Algorithms in Allergy: General Allergen Molecule‐Based Algorithm for Allergen‐Specific Immunotherapy
by: Huey‐Jy Huang, et al.
Published: (2026)

Making Peanuts Safer: Autoclaving as a Heat and Pressure Strategy to Increase Peanut Tolerability
by: Damian Stodulski, et al.
Published: (2026)

Recombinant Allergy Vaccine‐Induced Transmission of Maternal Allergen‐Specific Neutralizing IgG
by: George B. Pasikhov, et al.
Published: (2025)

The Evolution of Sesame Seed Allergy Over Time
by: Ru‐Xin Foong, et al.
Published: (2026)

Allergen‐Specific B Cell Responses Following Desensitisation and Natural Tolerance to Cow's Milk Allergy
by: Mohamed H. Shamji, et al.
Published: (2024)

Biphasic Effects on Allergen‐Specific Type 2 Memory B Cells Over 18 Months Sublingual Immunotherapy for House Dust Mite Allergy
by: Lin Hsin, et al.
Published: (2026)

Optimising the Diagnosis of Sesame Seed Allergy With the Basophil Activation Test
by: Ru‐Xin Foong, et al.
Published: (2026)

Design of an Ara h 2 hypoallergen from conformational epitopes
by: Jungki Min, et al.
Published: (2024)

Wildfires and Respiratory Allergy
by: Gennaro D'Amato, et al.
Published: (2025)

Trace Elements in Allergy: Narrative Review
by: Michal Ordak, et al.
Published: (2026)

A Gestational Supplementation With 2′‐Fucosyllactose Is an Effective Strategy to Prevent Food Allergy
by: A. Rousseaux, et al.
Published: (2024)

Algorithms in Allergy: Hereditary Angioedema
by: Konrad Bork, et al.
Published: (2026)

Peanut Component‐Specific IgE and IgG4 Are Modulated by Sublingual Immunotherapy and Are Associated With Remission in 1–4‐Year‐Old Children
by: Neel Singh, et al.
Published: (2025)

Allergen‐Specific IgE is a Stronger Predictor of Remission Following Peanut Oral Immunotherapy Than Age in Children Aged 1–10 Years
by: Sarah E. Ashley, et al.
Published: (2024)

Legends of Allergy and Immunology: Antonino Romano
by: María J. Torres, et al.
Published: (2025)

Legends of Allergy and Immunology: Werner Pichler
by: Lukas Joerg, et al.
Published: (2025)

Recombinant Hypoallergenic Cat Allergy Vaccines
by: Daria Trifonova, et al.
Published: (2025)

Legends of Allergy—Lawrence B. Schwartz
by: Gunnar P. Nilsson
Published: (2026)

Fish Allergenicity Ladder and Parvalbumin Epitopes for Predicting Clinical Cross‐Reactivity and Reintroduction in Chinese Population
by: Christine Y. Y. Wai, et al.
Published: (2025)

Secretion of Peanut Protein With IgE Crosslinking Capacity in Human Milk
by: Amy D. Burris, et al.
Published: (2025)

Novel Biomarkers and Diagnostic Tools in Food Allergy
by: Supinda Bunyavanich, et al.
Published: (2025)

Specific IgE to Chlorhexidine and Specific‐to‐Total‐IgE Ratio in Perioperative Chlorhexidine Allergy: Assessment of Clinical Significance
by: Nils Vlaeminck, et al.
Published: (2026)

Autoclaved Peanuts Exhibit Reduced Immunoglobulin E Binding and Improved Oral Tolerability
by: Casey G. Cohen, et al.
Published: (2026)

The stimulation of TH2 cells results in increased IL‐5 and IL‐13 production via the H4 receptor
by: Eirini Nikolouli, et al.
Published: (2024)

Allergy in Australia
by: Robert J. Boyle
Published: (2026)

Algorithms in Allergy: Diagnosis and Treatment of Pollen Food Syndrome
by: R. Asero, et al.
Published: (2026)

Childhood Asthma and Allergy Are Related to Accelerated Epigenetic Aging
by: Miriam Leskien, et al.
Published: (2025)